Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1998 Mar;72(3):2335-40.
doi: 10.1128/JVI.72.3.2335-2340.1998.

A novel point mutation at position 156 of reverse transcriptase from feline immunodeficiency virus confers resistance to the combination of (-)-beta-2',3'-dideoxy-3'-thiacytidine and 3'-azido-3'-deoxythymidine

R A Smith  1 , K M Remington, B D Preston, R F Schinazi, T W North
Affiliations

A novel point mutation at position 156 of reverse transcriptase from feline immunodeficiency virus confers resistance to the combination of (-)-beta-2',3'-dideoxy-3'-thiacytidine and 3'-azido-3'-deoxythymidine

R A Smith et al. J Virol. 1998 Mar.

Abstract

Mutants of feline immunodeficiency virus (FIV) resistant to (-)-beta-2',3'-dideoxy-3'-thiacytidine (3TC) were selected by culturing virus in the presence of increasing stepwise concentrations of 3TC. Two plaque-purified variants were isolated from the original mutant population, and both of these mutants were resistant to 3TC. Surprisingly, these mutants were also phenotypically resistant to 3'-azido-3'-deoxythymidine (AZT) and to the combination of 3TC and AZT. Purified reverse transcriptase (RT) from one of these plaque-purified mutants was resistant to the 5'-triphosphates of 3TC and AZT. DNA sequence analysis of the RT-encoding region of the pol gene amplified from the plaque-purified mutants revealed a Pro-to-Ser mutation at position 156 of RT. A site-directed mutant of FIV engineered to contain this Pro-156-Ser mutation was resistant to 3TC, AZT, and the combination of 3TC and AZT, confirming the role of the Pro-156-Ser mutation in the resistance of FIV to these two nucleoside analogs. This represents the first report of a lentiviral mutant resistant to the combination of AZT and 3TC due to a single, unique point mutation.

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
Susceptibility to inhibition by 3TC of FIV 34TF10 (▪) and the plaque-purified 3TC-resistant mutants 3TR-3c (▵) and 3TR-7c (○). Results are from three or more experiments, with four determinations per experiment. Bars represent standard errors of the means.
FIG. 2
FIG. 2
Nucleotide and deduced amino acid sequences of the region of the FIV pol gene surrounding position 2801. The corresponding amino acid sequence from HIV-1 is also shown for comparison. Note that HIV-1 and FIV RTs exhibit extensive homology in this region and that the FIV sequence is displaced by one residue relative to the HIV-1 sequence. Nucleotide sequence data for 3TR-3c and 3TR-7c were compared to the sequence data for FIV 34TF10. Mutations are shown in boldface.
FIG. 3
FIG. 3
Susceptibility to inhibition by the combination of 3TC and AZT of 34TF10 (□), 3TR-3c (▪), 3TR-7c (•), FIVMet183Val (○), FIVMet183Thr (▴), and FIVPro156Ser (▵). Values in the plot represent equimolar concentrations of 3TC plus AZT. For example, a 1 μM value for the drug combination represents 1 μM 3TC plus 1 μM AZT. Results are from three experiments with four determinations per experiment. Bars represent standard errors of the means and are omitted when the error is too small to be shown.
See this image and copyright information in PMC

References

    1. Ackley C D, Yamamoto J K, Levy N, Pedersen N C, Cooper M D. Immunologic abnormalities in pathogen-free cats experimentally infected with feline immunodeficiency virus. J Virol. 1990;64:5652–5655. - PMC - PubMed
    1. Arts E J, Wainberg M A. Mechanisms of nucleoside analog antiviral activity and resistance during human immunodeficiency virus reverse transcription. Antimicrob Agents Chemother. 1996;40:527–540. - PMC - PubMed
    1. Back N K T, Nijhuis M, Keulen W, Boucher C A B, Essink B B O, van Kuilenburg A B P, van Gennip A H, Berkhout B. Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme. EMBO J. 1996;15:4040–4049. - PMC - PubMed
    1. Barlough J E, Ackley C D, George J W, Levy N, Acevedo R, Moore P F, Rideout B A, Cooper M D, Pedersen N C. Acquired immune dysfunction in cats with experimentally induced feline immunodeficiency virus infection: comparison of short-term and long-term infections. J Acquired Immune Defic Syndr. 1991;4:219–227. - PubMed
    1. Beach J W, Jeong L S, Alves A J, Pohl D, Kim H O, Chang C-N, Doong S-L, Schinazi R F, Cheng Y-C, Chu C K. Synthesis of enantiomerically pure (2′R,5′S)-(−)-1-[2-(hydroxymethyl)-oxathiolan-5-yl]cytosine as a potent antiviral agent against hepatitis B virus (HBV) and human immunodeficiency virus (HIV) J Org Chem. 1992;57:2217–2219.

Publication types

MeSH terms

LinkOut - more resources